{
  "columns": [
    "Antibody",
    "Brand name",
    "Approval date",
    "Type",
    "Target",
    "Approved treatment(s)"
  ],
  "data": [
    [
      "Alemtuzumab",
      "Campath",
      "2001",
      "humanized",
      "CD52",
      "Chronic lymphocytic leukemia"
    ],
    [
      "Bevacizumab",
      "Avastin",
      "2004",
      "humanized",
      "vascular endothelial growth factor",
      "colorectal cancer"
    ],
    [
      "Brentuximab vedotin",
      "Adcetris",
      "2011",
      "chimeric",
      "CD30",
      "Hodgkin lymphoma , Anaplastic large-cell lymphoma"
    ],
    [
      "Cetuximab",
      "Erbitux",
      "2004",
      "chimeric",
      "epidermal growth factor receptor",
      "colorectal cancer"
    ],
    [
      "Gemtuzumab ozogamicin",
      "Mylotarg",
      "2000",
      "humanized",
      "CD33",
      "acute myelogenous leukemia (with calicheamicin )"
    ],
    [
      "Panitumumab",
      "Vectibix",
      "2006",
      "human",
      "epidermal growth factor receptor",
      "colorectal cancer"
    ],
    [
      "Rituximab",
      "Rituxan, Mabthera",
      "1997",
      "chimeric",
      "CD20",
      "non-Hodgkin lymphoma"
    ]
  ]
}